Cancer therapy presents unique challenges in drug delivery, requiring precise targeting and controlled release to maximize efficacy and minimize toxicity. This book addresses the specific obstacles faced in delivering anticancer agents, including drug resistance, heterogeneous tumor environments, and the need for targeted delivery systems. It explores advanced drug delivery strategies such as liposomal formulations, polymeric nanoparticles, and antibody-drug conjugates designed to overcome these challenges. Aimed at oncologists, pharmaceutical scientists, and biomedical engineers, the book provides comprehensive solutions and innovative approaches to enhance the effectiveness of cancer therapeutics through optimized drug delivery mechanisms.
Ruby Ford is an expert dermatologist specializing in drug delivery challenges for cancer therapy, focusing on optimizing the administration and effectiveness of pharmacological treatments for skin cancers such as melanoma and basal cell carcinoma. Her research investigates the barriers to effective drug delivery, including tumor microenvironment characteristics, drug resistance mechanisms, and the limitations of conventional delivery methods. Ruby has published extensively on innovative drug delivery systems, such as liposomes, microneedles, and targeted nanoparticles, to overcome these challenges and enhance the therapeutic outcomes of cancer treatments. She has developed comprehensive drug delivery protocols that address the specific needs of oncological dermatological therapies.